Table 5. Peak aortic velocity at study initiation and at 36 months.
Control Group | Nitisinone-Treated Group | ||||
---|---|---|---|---|---|
Patient # | Baseline Velocity (m/s) |
Final Velocity (m/s) |
Patient # | Baseline Velocity (m/s) |
Final Velocity (m/s) |
102 | 1.6 | 1.4 | 137 | 1.1 | 1.3 |
117 | 1.5 | 1.9 | 126 | 1.9 | 1.9 |
130 | 2.1 | 2.6 | 107 | 1.8 | 1.7 |
133 | 1.8 | 2.1 | 135 | 1.3 | 1.2 |
105 | 2.0 | 1.8 | 123 | 1.0 | 1.4 |
1 | 1.2 | 1.1 | 110 | 1.0 | 1.2 |
119 | 1.7 | 1.3 | 113 | 1.2 | 1.7 |
3 | 1.3 | 2.0 | 132 | 1.5 | 1.1 |
127 | 1.8 | 2.4 | 128 | 0.9 | 1.1 |
121 | 1.8 | 2.0 | 118 | 1.3 | 1.9 |
138 | 2.6 | 3.6 | 136 | 1.4 | 1.3 |
124 | 2.7 | 3.0 | 2 | 1.4 | 1.1 |
104 | 1.2 | Discontinued Study | 101 | 2.4 | 2.4 |
109 | 1.1 | Discontinued Study | 120 | 1.1 | 1.3 |
116 | 1.3 | 1.5 | 129 | 1.0 | 1.9 |
114 | 1.9 | 2.1 | 112 | 2.2 | 2.4 |
111 | 1.3 | 1.1 | 106 | 1.3 | 1.6 |
134 | 2.5 | 2.8 | 122 | 3.7 | 4.3 |
131 | 1.9 | 2.3 | 115 | 1.7 | Deceased |
125 | 1.9 | 1.8 | 103 | Replaced | Replaced |
Aortic sclerosis (peak velocity 2.0-2.5 m/s) is italicized. Aortic stenosis (peak velocity ≥2.5 m/s) is in bold.